Skip to search
Skip to main content
Back to Search
Start Over
OBINUTUZUMAB PLUS CHLORAMBUCIL VERSUS IBRUTINIB IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 DISRUPTIONS. A CAMPUS CLL STUDY
Authors :
Visentin, A. Pravato, S. Mauro, F. R. Pietrasanta, D. Fresa, A. Vitale, C. Ciolli, S. Cassin, R. Cibien, F. Sportoletti, P. Gentile, M. Gian Matteo Rigolin Quaglia, F. M. Murru, R. Gozzetti, A. Molica, S. Marchetti, M. Scarfo, L. Guardalben, E. Avitabile, A. Reda, G. Coscia, M. Laurenti, L. Pizzolo, G. Semenzato, G. Foa, R. Cuneo, A. Trentin, L.
Source :
Web of Science
Details
Database :
OpenAIRE
Journal :
Web of Science
Accession number :
edsair.dedup.wf.001..9e365cd1231ace83320d7ab95fda7b7c